London
· Delayed Price · Currency is GBP · Price in USDBristol-Myers Squibb Company Statistics
Total Valuation
Bristol-Myers Squibb Company has a market cap or net worth of GBP 92.48 billion. The enterprise value is 126.75 billion.
| Market Cap | 92.48B |
| Enterprise Value | 126.75B |
Important Dates
The next estimated earnings date is Thursday, February 6, 2025.
| Earnings Date | Feb 6, 2025 |
| Ex-Dividend Date | Jan 3, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -3.52% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.02B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.10, with an EV/FCF ratio of 12.31.
| EV / Earnings | -23.41 |
| EV / Sales | 3.36 |
| EV / EBITDA | 8.10 |
| EV / EBIT | 17.71 |
| EV / FCF | 12.31 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 2.99.
| Current Ratio | 1.24 |
| Quick Ratio | 1.02 |
| Debt / Equity | 2.99 |
| Debt / EBITDA | 2.62 |
| Debt / FCF | 3.73 |
| Interest Coverage | 5.05 |
Financial Efficiency
Return on equity (ROE) is -31.33% and return on invested capital (ROIC) is 8.20%.
| Return on Equity (ROE) | -31.33% |
| Return on Assets (ROA) | 6.07% |
| Return on Capital (ROIC) | 8.20% |
| Revenue Per Employee | 1.04M |
| Profits Per Employee | -158,803 |
| Employee Count | 34,100 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 3.97 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.34% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +42.34% |
| 50-Day Moving Average | 56.39 |
| 200-Day Moving Average | 49.15 |
| Relative Strength Index (RSI) | 49.73 |
| Average Volume (20 Days) | 53,060 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.18 |
Income Statement
In the last 12 months, Bristol-Myers Squibb Company had revenue of GBP 35.39 billion and -5.42 billion in losses. Loss per share was -2.67.
| Revenue | 35.39B |
| Gross Profit | 26.85B |
| Operating Income | 6.71B |
| Pretax Income | -5.13B |
| Net Income | -5.42B |
| EBITDA | 14.30B |
| EBIT | 6.71B |
| Loss Per Share | -2.67 |
Balance Sheet
The company has 6.04 billion in cash and 38.38 billion in debt, giving a net cash position of -32.10 billion.
| Cash & Cash Equivalents | 6.04B |
| Total Debt | 38.38B |
| Net Cash | -32.10B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.83B |
| Book Value Per Share | 6.31 |
| Working Capital | 4.06B |
Cash Flow
In the last 12 months, operating cash flow was 11.19 billion and capital expenditures -895.32 million, giving a free cash flow of 10.30 billion.
| Operating Cash Flow | 11.19B |
| Capital Expenditures | -895.32M |
| Free Cash Flow | 10.30B |
| FCF Per Share | n/a |
Margins
Gross margin is 75.87%, with operating and profit margins of 18.95% and -15.30%.
| Gross Margin | 75.87% |
| Operating Margin | 18.95% |
| Pretax Margin | -14.50% |
| Profit Margin | -15.30% |
| EBITDA Margin | 40.40% |
| EBIT Margin | 18.95% |
| FCF Margin | 29.10% |
Dividends & Yields
This stock pays an annual dividend of 1.87, which amounts to a dividend yield of 2.58%.
| Dividend Per Share | 1.87 |
| Dividend Yield | 2.58% |
| Dividend Growth (YoY) | 0.96% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | 3.52% |
| Shareholder Yield | 6.10% |
| Earnings Yield | -5.85% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bristol-Myers Squibb Company has an Altman Z-Score of 1.91. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.91 |
| Piotroski F-Score | n/a |